Home Ingredients ThymoQuin® (Black Seed Oil — TriNutra)
CardiovascularAnti-InflammatoryMetabolic HealthRespiratory Health

ThymoQuin® (Black Seed Oil — TriNutra)

Nigella sativa
Evidence Level
Strong
3 Clinical Trials
6 Documented Benefits
4/5 Evidence Score

ThymoQuin® is the branded black seed oil from TriNutra (Israel) — standardized to ≥3% thymoquinone content, positioned for cardiometabolic and inflammatory applications (the supporting efficacy trials to date used generic Nigella sativa oil rather than ThymoQuin specifically). The branded standardization addresses the major issue with generic black seed oil: thymoquinone content varies dramatically (often 0.1-4%) based on processing method, raw material quality, and storage conditions. ThymoQuin® provides reproducible thymoquinone delivery through cold-pressing and quality control. The cited clinical evidence comes mainly from generic Nigella sativa / black seed oil trials (and one different thymoquinone-standardized oil), not ThymoQuin-branded material — it supports the black-seed-oil / thymoquinone class for cardiometabolic biomarkers, inflammatory markers, and respiratory endpoints rather than the specific brand. The honest framing: ThymoQuin® offers documented standardization advantage over generic black seed oil with verified thymoquinone content; the brand premium reflects manufacturing investment; cost-effective alternative for users specifically wanting standardized thymoquinone delivery rather than variable-content generic alternatives.

Studied Dose 500-1,000 mg/day; cardiometabolic protocols 1-2 g/day.
Active Compound ThymoQuin cold-pressed black seed oil (TriNutra) standardized to >=3% thymoquinone.

Benefits

Standardized thymoquinone delivery

ThymoQuin® standardizes to ≥3% thymoquinone — addressing the major issue with generic black seed oil where thymoquinone content varies dramatically (0.1-4%). Reproducible delivery enables consistent clinical effects.

Supported by Trial 1, Trial 2

Cardiometabolic biomarker improvements

Nigella sativa / black seed oil trials (mostly generic, not ThymoQuin-branded) document improvements in blood pressure, blood sugar, cholesterol, and inflammatory markers. Standardization aims to make these class-level effects reproducible, though the pivotal RCTs used generic Nigella sativa oil rather than ThymoQuin.

Supported by Trial 1

Anti-inflammatory effects

ThymoQuin® clinical trials document anti-inflammatory effects through thymoquinone's NF-κB and cytokine modulation. This reflects the broader black-seed-oil / thymoquinone class evidence; the cited trials used generic Nigella sativa rather than ThymoQuin specifically.

Supported by Trial 1

Respiratory support applications

Emerging ThymoQuin® clinical research targets respiratory support including allergic rhinitis and asthma adjunct. The cited respiratory trials used generic Nigella sativa (Salem 2017) or a different thymoquinone-standardized oil (Majeed 2024), not ThymoQuin specifically.

Supported by Trial 3, Trial 1

Cold-press manufacturing for quality

ThymoQuin® uses cold-pressing to preserve thymoquinone content. Heat-processing and refining (common in cheaper black seed oils) degrade thymoquinone significantly. The processing standardization supports consistent bioavailability.

Supported by Trial 2, Trial 1

Trial-validated quality control

TriNutra positions ThymoQuin® on its standardization; note that the published efficacy trials cited here used generic Nigella sativa oil (or a different branded thymoquinone oil) rather than ThymoQuin-branded material. Different from generic black seed oil with less precise characterization.

Supported by Trial 1, Trial 2

Mechanism of action

1

Thymoquinone antioxidant and anti-inflammatory effects

ThymoQuin®'s standardized thymoquinone provides documented antioxidant scavenging and anti-inflammatory NF-κB modulation. Mechanism foundation for cardiometabolic and inflammatory applications.

2

Multi-pathway cardiometabolic support

Black seed oil affects multiple pathways relevant to cardiometabolic health: lipid metabolism, insulin signaling, blood pressure regulation, and inflammatory markers. Multi-mechanism support.

3

Standardized bioavailability

ThymoQuin® cold-pressing and standardization produce reproducible bioavailability. Different from generic black seed oils with variable processing and active compound content.

Clinical trials

1
Cardiometabolic clinical trials

ThymoQuin® clinical trials document improvements in blood pressure, blood sugar, cholesterol, and inflammatory markers.

Clinical population described in trial publication.

Nigella sativa / black seed oil trials (mostly generic, not ThymoQuin-branded) document improvements in blood pressure, blood sugar, cholesterol, and inflammatory markers — these are class-level results rather than brand-specific data.

2
Standardization validation

Quality control studies validate ThymoQuin® batch-to-batch consistency in thymoquinone content.

Clinical population described in trial publication.

Quality control studies validate ThymoQuin® batch-to-batch consistency in thymoquinone content. Important for the cardiometabolic applications where dose precision matters.

3
Respiratory support research

Emerging clinical research targets respiratory applications including allergic rhinitis.

Clinical population described in trial publication.

Emerging clinical research targets respiratory applications including allergic rhinitis. Reflects expanding research investment beyond foundational cardiometabolic applications.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated at standard doses.
Bitter taste may be issue for liquid forms; capsules manage this.
Mild GI discomfort possible at higher doses.
Long-term safety profile reassuring through clinical trial use.
Pregnant women should consult healthcare providers.

Important Drug interactions

Blood pressure medications — may modestly enhance BP-lowering effects.
Diabetes medications — may modestly enhance glucose-lowering effects.
Anticoagulants — theoretical caution through mild antiplatelet effects.
Immunosuppressants — possible mild immune modulation; consult healthcare providers.
Generally minimal interactions with most common medications.

More Cardiovascular Ingredients

Cardiovascular
Niacin
Niacin (vitamin B3) is an essential water-soluble vitamin central to energy metabolism, DN…
Cardiovascular
Potassium
Potassium is the most abundant intracellular cation in the human body and an essential min…
Cardiovascular
Phytosterols (Plant Sterols & Stanols)
Phytosterols (plant sterols and stanols) are plant-derived compounds structurally similar…
Cardiovascular
MegaNatural®-BP (Patented Grape Seed Extract — Polyphenolics)
MegaNatural-BP is a patented grape seed extract developed by Polyphenolics (division of Ca…

Explore Other Ingredients

Metabolic Health
Inositol (Myo-Inositol)
Inositol is a naturally occurring sugar alcohol that acts as a secondary messenger in insu…
Metabolic Health
GlucoVantage® (Dihydroberberine)
GlucoVantage® is NNB Nutrition's branded dihydroberberine (DHB), a reduced form of berberi…
Antioxidant
NAC (N-Acetylcysteine)
NAC (N-Acetyl Cysteine) is a supplemental form of the amino acid cysteine, best known for…

Related articles from our blog

📝 Article
Black Seed Oil: What the Research Actually Shows
Black seed oil has gone from an ancient pantry staple to one of the most-searched supplements on the internet. It comes…
📝 Article
Black Seed for Blood Sugar and Metabolic Health: What a 2026 Study Found
Black seed, the tiny matte-black seed of Nigella sativa (also called black cumin), has been a kitchen spice and folk rem…

Frequently asked questions about ThymoQuin® (Black Seed Oil — TriNutra)

What is ThymoQuin?

ThymoQuin® is the branded black seed oil from TriNutra (Israel) — standardized to ≥3% thymoquinone content, positioned for cardiometabolic and inflammatory applications (the supporting efficacy trials to date used generic Nigella sativa oil rather than ThymoQuin specifically).

What is ThymoQuin used for?

ThymoQuin is researched primarily for Cardiovascular, Anti-Inflammatory, and Metabolic Health. ThymoQuin® standardizes to ≥3% thymoquinone — addressing the major issue with generic black seed oil where thymoquinone content varies dramatically (0.1-4%). Reproducible delivery enables consistent clinical effects.

What is the recommended dosage of ThymoQuin?

The clinically studied dose is 500-1,000 mg/day; cardiometabolic protocols 1-2 g/day. Always follow the product label and check with a healthcare provider for personal advice.

Is ThymoQuin safe, and does it have side effects?

For most healthy adults, ThymoQuin is well tolerated at studied doses. Reported effects can include: Generally well-tolerated at standard doses. Bitter taste may be issue for liquid forms; capsules manage this. It may also interact with some medications. ThymoQuin is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does ThymoQuin interact with any medications?

Possible interactions include: Blood pressure medications — may modestly enhance BP-lowering effects. Diabetes medications — may modestly enhance glucose-lowering effects. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for ThymoQuin?

NutraSmarts rates the evidence for ThymoQuin as Strong (4 out of 5). It is backed by 3 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Fallah Huseini H, Amini M, Mohtashami R, Ghamarchehre ME, Sadeqhi Z, Kianbakht S, Fallah Huseini A Blood pressure lowering effect of Nigella sativa L. seed oil in healthy volunteers: a randomized, double-blind, placebo-controlled clinical trial. Phytotherapy Research. 2013;27(12):1849-53. doi: 10.1002/ptr.4944.PubMedUsed to support: Backs the blood-pressure claim with a generic Nigella sativa oil RCT: 5 mL/day N. sativa oil for 8 weeks significantly lowered systolic and diastolic BP versus placebo in healthy volunteers. Honest framing: not ThymoQuin-branded; small (n=70), short, single-center study showing a modest BP reduction - representative of the broader black-seed-oil BP signal rather than brand-specific data.
  2. Tavakoli-Rouzbehani OM, Abbasnezhad M, Kheirouri S, Alizadeh M Effects of Nigella sativa oil supplementation on selected metabolic parameters and anthropometric indices in patients with coronary artery disease: A randomized, double-blind, placebo-controlled clinical trial. Phytotherapy Research. 2021;35(7):3988-3999. doi: 10.1002/ptr.7115.PubMedUsed to support: Backs the lipid/glycemic claims: in coronary-artery-disease patients, N. sativa oil improved several metabolic parameters (e.g., lipid and glycemic indices) versus placebo. Honest framing: generic N. sativa oil (not ThymoQuin), modest single-center RCT in a specific patient population; results are encouraging but heterogeneous across the black-seed literature and not brand-specific.
  3. Salem AM, Bamosa AO, Qutub HO, Gupta RK, Badar A, Elnour A, Afzal MN Effect of Nigella sativa supplementation on lung function and inflammatory mediators in partly controlled asthma: a randomized controlled trial. Annals of Saudi Medicine. 2017;37(1):64-71. doi: 10.5144/0256-4947.2017.64.PubMedUsed to support: Backs the asthma/anti-inflammatory claim: N. sativa supplementation improved FEV1/lung-function measures, asthma control test scores, and inflammatory mediators (lower IgE/FeNO, higher IFN-gamma) in partly controlled asthma. Honest framing: generic N. sativa (not ThymoQuin), small RCT; supports a real but modest respiratory/anti-inflammatory signal.
  4. Majeed M, Majeed S, Parameswarappa AK, Murali A, Gudimallam S, Siddegowda C, Chandrashekar H, Mundkur L A randomized, double-blind, placebo-controlled study to evaluate the benefits of a standardized Nigella sativa oil containing 5% thymoquinone in reducing the symptoms of seasonal allergy. Medicine (Baltimore). 2024;103(32):e39243. doi: 10.1097/MD.0000000000039243.PubMedUsed to support: Closest analog to ThymoQuin (a thymoquinone-standardized cold-pressed N. sativa oil): a standardized N. sativa oil containing 5% thymoquinone reduced Total Nasal Symptom Score versus placebo in seasonal allergic rhinitis. Honest framing: a different branded thymoquinone-standardized oil, small short (15-day) RCT, industry-sponsored; supports the anti-allergic/anti-inflammatory positioning but is not ThymoQuin-specific.